Showing results (141-150 of 160) with videos related to
Sort By:
Pageof 16
Acta Neuropathologica Communications|November 1, 2017
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomasRalph Salloum, Melissa K McConechy, Leonie G Mikael, et al.Neuro-Oncology|April 19, 2020
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trialGirish Dhall, Sharon H O'Neil, Lingyun Ji, et al.Pediatric Blood & Cancer|May 20, 2022
Factors influencing outcomes of older children with medulloblastoma over 15 years in Peru, a resource-limited settingRosdali Y Diaz-Coronado, James Brandon Reinecke, Joseph R Stanek, et al.Nature Communications|August 26, 2025
Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriersVallijah Subasri, Benjamin Brew, Brianne Laverty, et al.Neuro-Oncology|December 25, 2016
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start dataMartin Mynarek, Barry Pizer, Christelle Dufour, et al.Acta Neuropathologica Communications|November 6, 2020
Characterizing temporal genomic heterogeneity in pediatric low-grade gliomasMargot A Lazow, Lindsey Hoffman, Austin Schafer, et al.Cancer Research Communications|June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni SyndromeVallijah Subasri, Nicholas Light, Nisha Kanwar, et al.The American Journal of Surgical Pathology|October 19, 2020
YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood MeningiomasKathleen M Schieffer, Vibhuti Agarwal, Stephanie LaHaye, et al.Nature Communications|January 5, 2023
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosisNicholas Light, Mehdi Layeghifard, Ayush Attery, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer SusceptibilityNardin Samuel, Gavin Wilson, Mathieu Lemire, et al.Pageof 16